Home › NDC Lookup › Ingredients › Titanium Dioxide › 98132-0896-08
bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Ivory Titanium Dioxide 25 g/100g Powder, 8 g — NDC 98132-0896-08 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Ivory Titanium Dioxide 25 g/100g Powder, 8 g — NDC 98132-896-08 (Billing 98132-0896-08)

by Orveon Global US LLC · 8 g in 1 JAR

This is a package of 8 g of bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Ivory Titanium Dioxide 25 g/100g Powder from Orveon Global US LLC, marketed since Feb 2017 and currently FDA-listed.

NDC 98132-0896-08
🏷️ FDA NDC (as labeled) 98132-896-08 billing pads the product segment with a zero
This package
Contains8 g Pack sizes3 compare ↓
Product page 98132-0896-02 Also comes in: 2 g 98132-896-02 75 g 98132-896-75
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 98132-896-08 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
98132 labeler · 896 product · 08 package
Package marketed since
Feb 1, 2017
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 9813289608 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 98132-896-08
Product NDC 98132-896
11-digit billing NDC 98132089608
UNII 15FIX9V2JP
Application # M020
SPL Set ID 15c92bce-75f4-40e3-ae28-9bcbc241c8e9
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2017-02-01
Route TOPICAL
Dosage form POWDER
Substance TITANIUM DIOXIDE
Why two NDCs? The FDA registers this code as 98132-896-08 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 98132-0896-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is a powder foundation makeup product applied to skin that contains titanium dioxide as its active ingredient. Titanium dioxide is commonly used in sunscreen and sun protection products as a broad spectrum ultraviolet (UV) filter to help protect skin from both UVA and UVB rays. This particular product is marketed as an over-the-counter monograph drug, meaning it follows FDA's established safety and effectiveness guidelines for sunscreen products in this category rather than being individually reviewed. The product is formulated to provide sun protection with a stated SPF 15 rating while also functioning as a cosmetic foundation.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 2 g 75 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
98132-0896-02 98132-896-02 Main listing 2 g in 1 JAR 2017-02-01 — Active
98132-0896-08 You're viewing this 8 g in 1 JAR 2017-02-01 — Active
98132-0896-75 98132-896-75 .75 g in 1 JAR 2017-02-01 — Active

Pack size FAQ

What quantity is in this package?
This package contains 8 g — 8 g in 1 jar.
How does this package differ from NDC 98132-0896-02?
Both are bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Ivory Titanium Dioxide 25 g/100g Powder — the drug itself is identical. This page's package is the 8 g one, while NDC 98132-0896-02 is the 2 g package.
What NDC number is used to bill for this package of bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Ivory Titanium Dioxide 25 g/100g Powder?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
bareMinerals Original Foundation Broad Spectrum SPF 15 Fair Ivory 25 g/100g 98132-0894-02 Orveon 2 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Beige 25 g/100g 98132-0895-02 Orveon 2 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Ivory 25 g/100gthis 98132-0896-08 Orveon 8 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Nude 25 g/100g 98132-0897-02 Orveon 2 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Light Beige 25 g/100g 98132-0898-02 Orveon 2 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Neutral Ivory 25 g/100g 98132-0899-02 Orveon 2 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Neutral Medium 25 g/100g 98132-0900-02 Orveon 2 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Neutral Tan 25 g/100g 98132-0901-02 Orveon 2 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Soft Medium 25 g/100g 98132-0905-02 Orveon 2 g — — FDA listed —
bareMinerals Original Foundation Broad Spectrum SPF 15 Tan Nude 25 g/100g 98132-0906-02 Orveon 2 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2017
On the market since
Feb 2017
📍
2026
Currently FDA-listed
9 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerOrveon Global US LLC
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code98132
First marketedFeb 2017
Product typeHuman Otc Drug
Portfolio160 products on file

More NDCs from Orveon Global US LLC labeler code 98132

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 30 words ▾

Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

⏱️ Dosage and Administration 93 words ▾

Directions For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours children under 6 months: ask a doctor Sun protection measures. Spending tirne in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses

⚠️ Warnings 56 words ▾

Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 11 words ▾

Other information Protect this product from excessive heat and direct sun

🧪 Active Ingredient 5 words ▾

Active ingredient(s) Titanium dioxide 25%

🧪 Inactive Ingredients 11 words ▾

Inactive ingredients mica. may contain: titanium dioxide, iron oxides, bismuth oxychloride.

🎯 Purpose 2 words ▾

Purpose Sunscreen

📄 Do Not Use 8 words ▾

Do not use on damaged or broken skin

📄 When Using This Product 13 words ▾

When using this product keep out of eyes. Rinse with water to remove.

📄 Stop Use and Ask a Doctor If 9 words ▾

Stop use and ask a doctor if rash occurs

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 7 words ▾

Questions or comments? Call toll free 1-888-795-4747

📄 Package Label / Principal Display Panel ~2 min read ▾

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Fair Ivory bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 FAIR IVORY 02 net wt. 8 g / 0.28 oz. 83736 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Fair Ivory

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Golden Beige bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 GOLDEN BEIGE 13 net wt. 8 g / 0.28 oz. 83741 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Golden Beige

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Golden Ivory bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 GOLDEN IVORY 07 net wt. 8 g / 0.28 oz. 83738 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Golden Ivory

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Golden Nude bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 GOLDEN NUDE 16 net wt. 8 g / 0.28 oz. 84237 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Golden Nude

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Light Beige bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 LIGHT BEIGE 09 net wt. 8 g / 0.28 oz. 83739 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Light Beige

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Neutral Ivory bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 NEUTRAL IVORY 06 net wt. 8 g / 0.28 oz. 83737 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Neutral Ivory

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Neutral Medium bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 NEUTRAL MEDIUM 15 net wt. 8 g / 0.28 oz. 84236 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Neutral Medium

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Neutral Tan bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 NEUTRAL TAN 21 net wt. 8 g / 0.28 oz. 84239 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Neutral Tan

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Soft Medium bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 SOFT MEDIUM 11 net wt. 8 g / 0.28 oz. 83740 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Soft Medium

PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Tan Nude bareMinerals ® ORIGINAL FOUNDATION Broad Spectrum SPF 15 TAN NUDE 17 net wt. 8 g / 0.28 oz. 84238 PRINCIPAL DISPLAY PANEL - 2 g Jar Label - Tan Nude

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for bareMinerals Original Foundation Broad Spectrum SPF 15 Golden Ivory (this brand).

Top reported reactions

Hypersensitivity17
Abdominal Pain Upper13
Reaction To Excipient13
Madarosis11
Dyspnoea8
Erythema7
Pain In Extremity7

Reporter sex

95 reports

Serious outcomes

Hospitalization37
Death23
Disabling14
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 23 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Orveon Global US LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 2 g (98132-0896-02), 75 g (98132-0896-75). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Orveon Global US LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 98132-0895-02 · Orveon 98132-0897-02 · Orveon →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.